Evidence map›Paper›PMID 29880077›Full record

ArticleEpidemiology and infection2018

Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014-2015 and 2015-2016.

H E Segaloff, J G Petrie, R E Malosh, C K Cheng, E J McSpadden, J M Ferdinands, L Lamerato, A S Lauring, A S Monto, E T Martin

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Outcomes among critically ill adults with influenza infection.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2021
    Article
  9. Article
  10. Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  11. Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

H E SegaloffUniversity of Michigan School Of Public Health,Ann Arbor, Michigan 48109,USA.ORCID 0000-0003-4716-7468
J G PetrieUniversity of Michigan School Of Public Health,Ann Arbor, Michigan 48109,USA.
R E MaloshUniversity of Michigan School Of Public Health,Ann Arbor, Michigan 48109,USA.
C K ChengUniversity of Michigan School Of Public Health,Ann Arbor, Michigan 48109,USA.
E J McSpaddenUniversity of Michigan School Of Public Health,Ann Arbor, Michigan 48109,USA.
J M FerdinandsInfluenza Division,Centers for Disease Control and Prevention,Atlanta, Georgia 30333,USA.
L LameratoHenry Ford Health System,Detroit, Michigan 48202,USA.
A S LauringDepartment of Internal Medicine,Division of Infectious Diseases,University of Michigan,Ann Arbor, Michigan 48109,USA.
A S MontoUniversity of Michigan School Of Public Health,Ann Arbor, Michigan 48109,USA.
E T MartinUniversity of Michigan School Of Public Health,Ann Arbor, Michigan 48109,USA.
University of Michigan · USCenters for Disease Control and Prevention · USHenry Ford Health System · US

Funding

Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness ResearchU01IP000474 · IP · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S · 2011 to 2015
$6.2M
US Hospital Vaccine Effectiveness (VE) Network - SupplementU01IP000974 · IP · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S · 2015 to 2019
$4.5M
NCIRD CDC HHS U01 IP000474NCIRD CDC HHS U01 IP000974
6 · The paper itself

Abstract

Our objective was to identify predictors of severe acute respiratory infection in hospitalised patients and understand the impact of vaccination and neuraminidase inhibitor administration on severe influenza. We analysed data from a study evaluating influenza vaccine effectiveness in two Michigan hospitals during the 2014-2015 and 2015-2016 influenza seasons. Adults admitted to the hospital with an acute respiratory infection were eligible. Through patient interview and medical record review, we evaluated potential risk factors for severe disease, defined as ICU admission, 30-day readmission, and hospital length of stay (LOS). Two hundred sixteen of 1119 participants had PCR-confirmed influenza. Frailty score, Charlson score and tertile of prior-year healthcare visits were associated with LOS. Charlson score >2 (OR 1.5 (1.0-2.3)) was associated with ICU admission. Highest tertile of prior-year visits (OR 0.3 (0.2-0.7)) was associated with decreased ICU admission. Increasing tertile of visits (OR 1.5 (1.2-1.8)) was associated with 30-day readmission. Frailty and prior-year healthcare visits were associated with 30-day readmission among influenza-positive participants. Neuraminidase inhibitors were associated with decreased LOS among vaccinated participants with influenza A (HR 1.6 (1.0-2.4)). Overall, frailty and lack of prior-year healthcare visits were predictors of disease severity. Neuraminidase inhibitors were associated with reduced severity among vaccine recipients.

Indexed as

Acute DiseaseAdolescentAdultAgedEnzyme InhibitorsFemaleFrailtyHealth StatusHumansInfluenza, HumanInfluenza VaccinesInpatientsIntensive Care UnitsInterviews as TopicLength of StayMaleEnzyme InhibitorsInfluenza VaccinesNeuraminidaseInfluenzarespiratory infectionsvaccines

Identifiers

PMID29880077
PMCPMC6089216
OpenAlexW2805217568

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.